A Novel Fusion Gene and a Common Α(0)-Thalassemia Deletion Cause Hemoglobin H Disease in a Chinese Family.

Ji-Wei Huang,Xuan Shang,Ying Zhao,Ren Cai,Xin-Hua Zhang,Xiao-Feng Wei,Fu Xiong,Xiang-Min Xu
DOI: https://doi.org/10.1016/j.bcmd.2013.01.013
IF: 2.372
2013-01-01
Blood Cells Molecules and Diseases
Abstract:Genetic recombination has been implicated as a mechanism that drives mutagenesis in the human globin gene clusters, either as a result of unequal crossover or gene conversion. In this paper, a novel fusion gene was identified in a Chinese girl with hemoglobin H disease. The proband's father was a compound heterozygote for the common −α4.2 deletion and this fusion gene, and her mother was heterozygous for the common −−SEA deletion (−−SEA/αα). Both her parents had a hypochromic and microcytic red cell phenotype and a normal hemoglobin level. Molecular studies revealed a compound heterozygote for the −−SEA deletion and this novel fusion gene and the patient had the clinical features of classic hemoglobin H disease. Sequence analysis revealed that the mutant gene was the result of a fusion between the α2 and ψα1 genes. The recombination began at exon 3 of α2 gene, crossing with exon 3 of the ψα1 gene. With this recombination, the conservative 3′UTR of the α2 gene was changed, and an extensive transcript with a new signal 1048bp 3′ to the terminating codon was found. The abnormal transcripts of the fusion gene read through the intergenic sequence.
What problem does this paper attempt to address?